269 related articles for article (PubMed ID: 7391842)
1. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection.
Som P; Atkins HL; Bandoypadhyay D; Fowler JS; MacGregor RR; Matsui K; Oster ZH; Sacker DF; Shiue CY; Turner H; Wan CN; Wolf AP; Zabinski SV
J Nucl Med; 1980 Jul; 21(7):670-5. PubMed ID: 7391842
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study for tumor detection using 18F-2-fluoro-deoxy-D-glucose: imaging of rabbit VX2-tumor with single photon gamma camera].
Abe Y; Matsuzawa T; Fukuda H; Endo S; Yamada K; Sato T; Ito M; Kubota K; Hatazawa J; Yoshioka S
Kaku Igaku; 1985 Mar; 22(3):389-91. PubMed ID: 3874982
[No Abstract] [Full Text] [Related]
3. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection.
Fukuda H; Matsuzawa T; Abe Y; Endo S; Yamada K; Kubota K; Hatazawa J; Sato T; Ito M; Takahashi T; Iwata R; Ido T
Eur J Nucl Med; 1982; 7(7):294-7. PubMed ID: 6981508
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
J Nucl Med; 1992 Nov; 33(11):1972-80. PubMed ID: 1432158
[TBL] [Abstract][Full Text] [Related]
5. Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in man.
Paul R; Johansson R; Kiuru A; Illukka T; Talvio T; Roeda D; Solin O; Söderström KO; Nordman E; Ahonen A
Nucl Med Commun; 1984 Oct; 5(10):641-6. PubMed ID: 6597912
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent.
Inoue T; Tomiyoshi K; Higuichi T; Ahmed K; Sarwar M; Aoyagi K; Amano S; Alyafei S; Zhang H; Endo K
J Nucl Med; 1998 Apr; 39(4):663-7. PubMed ID: 9544678
[TBL] [Abstract][Full Text] [Related]
7. Transient toxicity of 2-deoxy-2-[18F]fluoro-D-glucose in mammalian cells: concise communication.
Kassis AI; Adelstein SJ; Wolf AP; Fowler JG; Shiue CY
J Nucl Med; 1983 Nov; 24(11):1055-9. PubMed ID: 6631526
[TBL] [Abstract][Full Text] [Related]
8. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.
Kubota K; Ishiwata K; Kubota R; Yamada S; Tada M; Sato T; Ido T
J Nucl Med; 1991 Nov; 32(11):2118-23. PubMed ID: 1834814
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.
Paul R
J Nucl Med; 1987 Mar; 28(3):288-92. PubMed ID: 3469332
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose.
Yamada K; Endo S; Fukuda H; Abe Y; Yoshioka S; Itoh M; Kubota K; Hatazawa J; Satoh T; Matsuzawa T
Eur J Nucl Med; 1985; 10(7-8):341-5. PubMed ID: 3891350
[TBL] [Abstract][Full Text] [Related]
11. A new method using anhydrous [18F]fluoride to radiolabel 2-[18F]fluoro-2-deoxy-D-glucose.
Levy S; Elmaleh DR; Livni E
J Nucl Med; 1982 Oct; 23(10):918-22. PubMed ID: 7119887
[No Abstract] [Full Text] [Related]
12. F-18-labeled 3-deoxy-3-fluoro-D-glucose for the study of regional metabolism in the brain and heart.
Goodman MM; Elmaleh DR; Kearfott KJ; Ackerman RH; Hoop B; Brownell GL; Alpert NM; Strauss HW
J Nucl Med; 1981 Feb; 22(2):138-44. PubMed ID: 6970254
[TBL] [Abstract][Full Text] [Related]
13. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
Paul R; Roeda D; Johansson R; Ahonen A; Haaparanta M; Solin O; Sipilä H
Int J Rad Appl Instrum B; 1986; 13(1):7-12. PubMed ID: 3771240
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.
Gallagher BM; Ansari A; Atkins H; Casella V; Christman DR; Fowler JS; Ido T; MacGregor RR; Som P; Wan CN; Wolf AP; Kuhl DE; Reivich M
J Nucl Med; 1977 Oct; 18(10):990-6. PubMed ID: 903484
[TBL] [Abstract][Full Text] [Related]
16. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jun; 35(6):1067-75. PubMed ID: 8195872
[TBL] [Abstract][Full Text] [Related]
17. Preliminary imaging results with 18F-2-fluoro-2-deoxy-D-glucose.
Brownell GL; Ackerman RH; Strauss HW; Elmaleh DR; Cochavi S; Alpert N; Correia JA; Kearfott KJ; Taveras J
J Comput Assist Tomogr; 1980 Aug; 4(4):473-7. PubMed ID: 6771307
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.
Dearling JL; Flynn AA; Sutcliffe-Goulden J; Petrie IA; Boden R; Green AJ; Boxer GM; Begent RH; Pedley RB
J Nucl Med; 2004 Jan; 45(1):101-7. PubMed ID: 14734681
[TBL] [Abstract][Full Text] [Related]
19. Organ and tumor distribution of (18F)-2-fluoro-2-deoxy-D-glucose in fasting and non-fasting rats.
Paul R; Kiuru A; Söderström KO; Tuominen J; Johansson R; Haaparanta M; Roeda D; Solin O
Life Sci; 1987 Apr; 40(16):1609-16. PubMed ID: 3031405
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose.
Minn H; Paul R; Ahonen A
J Nucl Med; 1988 Sep; 29(9):1521-5. PubMed ID: 3137316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
